Fulcrum Asset Management LLP Acquires 27,889 Shares of Agilent Technologies, Inc. $A

Fulcrum Asset Management LLP acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 27,889 shares of the medical research company’s stock, valued at approximately $4,881,000.

Several other institutional investors have also modified their holdings of A. State Street Corp increased its stake in shares of Agilent Technologies by 0.7% during the second quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock worth $1,710,658,000 after purchasing an additional 89,598 shares in the last quarter. Wellington Management Group LLP boosted its holdings in Agilent Technologies by 2.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock worth $990,206,000 after buying an additional 198,253 shares during the last quarter. Deutsche Bank AG boosted its holdings in Agilent Technologies by 17.1% in the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after buying an additional 1,024,516 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Agilent Technologies by 87.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after buying an additional 2,440,360 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Agilent Technologies by 9.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,108,764 shares of the medical research company’s stock worth $240,336,000 after buying an additional 185,223 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities analysts have commented on A shares. Deutsche Bank Aktiengesellschaft started coverage on Agilent Technologies in a report on Monday, October 26th. They set a “buy” rating and a $190.00 target price for the company. HSBC lifted their price target on Agilent Technologies from $165.00 to $175.00 and gave the stock a “buy” rating in a research note on Tuesday, September 1st. TD Cowen boosted their price target on Agilent Technologies from $180.00 to $196.00 and gave the stock a “buy” rating in a research report on Tuesday, October 13th. Wells Fargo & Company increased their price objective on Agilent Technologies from $160.00 to $180.00 and gave the company an “overweight” rating in a research note on Friday, August 28th. Finally, Barclays increased their price objective on Agilent Technologies from $175.00 to $195.00 and gave the company an “overweight” rating in a research note on Wednesday, October 7th. Eighteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $181.45.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director owned 4,924 shares of the company’s stock, valued at $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Agilent Technologies Trading Up 3.0%

A opened at $180.09 on Tuesday. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $182.99. The stock has a market capitalization of $50.77 billion, a PE ratio of 35.45, a P/E/G ratio of 2.59 and a beta of 1.24. The business’s 50 day moving average price is $166.45 and its 200 day moving average price is $137.40. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The company’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period last year, the company earned $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th were paid a $0.2550 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Tuesday, October 6th. Agilent Technologies’s payout ratio is 20.08%.

Agilent Technologies Company Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research.

The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Agilent became an independent company in 1999 through a spin-off from Hewlett-Packard.